Dear OncoLink "Ask The Experts,"
Our 14 year old son was diagnosed with Chronic Myelogenous Leukemia 6 weeks ago. He is on Gleevec. We have been considering Bone Marrow Transplant but heard that Gleevec may be contraindicated in doing a BMT. Can you shed any light on this?
Selina M. Luger, MD, Director of the Leukemia Program and Assistant Professor of Medicine at the University of Pennsylvania, responds:
Being on Gleevec in no way makes patients ineligible for a bone marrow transplant. However, sometimes, the Gleevec is discontinued for some period of time before the transplant is performed.
Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.
Jun 17, 2011
Feb 2, 2012